Lung tumor discrimination by deep neural network model CanDo via DNA methylation in bronchial lavage

Bronchoscopic-assisted discrimination of lung tumors presents challenges, especially in cases with contraindications or inaccessible lesions. Through meta-analysis and validation using the HumanMethylation450 database, this study identified methylation markers for molecular discrimination in lung tu...

Full description

Saved in:
Bibliographic Details
Published iniScience Vol. 27; no. 6; p. 110079
Main Authors Yu, Zezhong, Li, Jieyi, Deng, Yi, Li, Chun, Ye, Maosong, Zhang, Yong, Huang, Yuqing, Wang, Xintao, Zhao, Xiaokai, Liu, Jie, Liu, Zilong, Yin, Xia, Mei, Lijiang, Hou, Yingyong, Hu, Qin, Huang, Yao, Wang, Rongping, Fu, Huiyu, Qiu, Rumeng, Xu, Jiahuan, Gong, Ziying, Zhang, Daoyun, Zhang, Xin
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 21.06.2024
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Bronchoscopic-assisted discrimination of lung tumors presents challenges, especially in cases with contraindications or inaccessible lesions. Through meta-analysis and validation using the HumanMethylation450 database, this study identified methylation markers for molecular discrimination in lung tumors and designed a sequencing panel. DNA samples from 118 bronchial washing fluid (BWF) specimens underwent enrichment via multiplex PCR before targeted methylation sequencing. The Recursive Feature Elimination Cross-Validation and deep neural network algorithm established the CanDo classification model, which incorporated 11 methylation features (including 8 specific to the TBR1 gene), demonstrating a sensitivity of 98.6% and specificity of 97.8%. In contrast, bronchoscopic rapid on-site evaluation (bronchoscopic-ROSE) had lower sensitivity (87.7%) and specificity (80%). Further validation in 33 individuals confirmed CanDo’s discriminatory potential, particularly in challenging cases for bronchoscopic-ROSE due to pathological complexity. CanDo serves as a valuable complement to bronchoscopy for the discriminatory diagnosis and stratified management of lung tumors utilizing BWF specimens. [Display omitted] •Meta-analysis found 13 genes significant in methylation for distinguishing lung cancer•Multiplex PCR with targeted methylation sequencing enhanced detection sensitivity•BWF methylation test had 98.6% sensitivity, 97.8% specificity in lung tumor diagnosis•TBR1 gene methylation may be important in the occurrence of lung cancer Disease; Cell; Computing methodology
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
These authors contributed equally
Lead contact
ISSN:2589-0042
2589-0042
DOI:10.1016/j.isci.2024.110079